The cost of cancer care is not related to its outcomes

Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: Storme, Guy, Dhaese, S, Corens, D, De Ridder, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130330/
https://www.ncbi.nlm.nih.gov/pubmed/27994643
http://dx.doi.org/10.3332/ecancer.2016.687
_version_ 1782470714631127040
author Storme, Guy
Dhaese, S
Corens, D
De Ridder, Mark
author_facet Storme, Guy
Dhaese, S
Corens, D
De Ridder, Mark
author_sort Storme, Guy
collection PubMed
description Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on the outcome but has a cost, which is as much as all the other actions such as diagnostic tools and treatments.
format Online
Article
Text
id pubmed-5130330
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-51303302016-12-19 The cost of cancer care is not related to its outcomes Storme, Guy Dhaese, S Corens, D De Ridder, Mark Ecancermedicalscience Short Communication Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on the outcome but has a cost, which is as much as all the other actions such as diagnostic tools and treatments. Cancer Intelligence 2016-10-28 /pmc/articles/PMC5130330/ /pubmed/27994643 http://dx.doi.org/10.3332/ecancer.2016.687 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Storme, Guy
Dhaese, S
Corens, D
De Ridder, Mark
The cost of cancer care is not related to its outcomes
title The cost of cancer care is not related to its outcomes
title_full The cost of cancer care is not related to its outcomes
title_fullStr The cost of cancer care is not related to its outcomes
title_full_unstemmed The cost of cancer care is not related to its outcomes
title_short The cost of cancer care is not related to its outcomes
title_sort cost of cancer care is not related to its outcomes
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130330/
https://www.ncbi.nlm.nih.gov/pubmed/27994643
http://dx.doi.org/10.3332/ecancer.2016.687
work_keys_str_mv AT stormeguy thecostofcancercareisnotrelatedtoitsoutcomes
AT dhaeses thecostofcancercareisnotrelatedtoitsoutcomes
AT corensd thecostofcancercareisnotrelatedtoitsoutcomes
AT deriddermark thecostofcancercareisnotrelatedtoitsoutcomes
AT stormeguy costofcancercareisnotrelatedtoitsoutcomes
AT dhaeses costofcancercareisnotrelatedtoitsoutcomes
AT corensd costofcancercareisnotrelatedtoitsoutcomes
AT deriddermark costofcancercareisnotrelatedtoitsoutcomes

Ejemplares similares